Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes (Q28372093)

2

0 references

A Beck

3

0 references

J Rawlings

4

0 references

D W Miller

5

0 references

B Clements

6

0 references

D G Pait

7

0 references

A Batenhorst

Quality-of-life assessment in patients with headache

8

0 references

language of work or name

English

0 references

publication date

January 1999

0 references

published in

Clinical Therapeutics

0 references

volume

21

0 references

issue

1

0 references

page(s)

190-204

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Measuring the functional status and well-being of patients with migraine headache.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Impact of migraine in the United States: data from the National Health Interview Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Healthcare resource and lost labour costs of migraine headache in the US.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Does quality of life differ among headache diagnoses? Analysis using the medical outcomes study instrument.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Development and validation of the Migraine-Specific Quality of Life Questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

MSQ: Migraine-Specific Quality-of-Life Questionnaire. Further investigation of the factor structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Sumatriptan use in a large group-model health maintenance organization.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Quality of life assessment among migraine patients treated with sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Measuring health-related quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Cost benefit of sumatriptan to an employer.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

High efficacy and low frequency of headache recurrence after oral sumatriptan. The Oral Sumatriptan Italian Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021

Oral sumatriptan in preventing headache recurrence after treatment of migraine attacks with subcutaneous sumatriptan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2800%2988278-8

7 January 2021